An examination of layoffs in pharmaceutical and biotechnology companies in Q3 shows that as the summer progressed, the number of layoffs per month declined. However, total layoffs per month surpassed ...
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the 2021 highs. "I look for wherever I can make the most amount of money, legally, ...
Investor's Business Daily on MSN
Biotech stock nears entry after FDA news; earnings on horizon
Krystal Biotech is engaged in developing genetic medicines. The biotech stock is near a buy point with earnings due soon.
Moderna was a huge pandemic name, but has struggled since the earlier days of the health crisis. The company is looking to introduce new products and then lower its R&D budget. Even after its sell-off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results